ERBB2 and breast carcinoma: To further uncover the mechanism of ganetespib-induced apoptosis in ErbB2+ breast cancer cells, we analyzed the expression and/or activation of key apoptotic markers involved in death receptor- and mitochondria-mediated pathways of cell death, after ganetespib treatment.